Clinical research is the cornerstone of medical innovation, yet access to clinical trials remains disproportionately limited to a small fraction of the population.
Enter Clinical Trials Access Collaborative (CTAC), an organization dedicated to making medical research more accessible, striving to ensure those who wish to participate in clinical trials can do so.
The collaboration is a scalable model that connects clinical trial sponsors, healthcare institutions, community organizations, and the research ecosystem to accelerate trial participation in communities with access gaps. Its goal is to create a network of connected clinical care sites closer to each community and equipped with tools and resources for sustainable participation in clinical research.
“Communities with higher rates of chronic conditions often have fewer opportunities to join trials,” says McKinsey Senior Expert and Associate Partner Tamara Baer, MD. “About 50 percent of clinical trials take place in 2 percent of US zip codes. If we can change these statistics, we can potentially improve health outcomes across generations.”
See how McKinsey helped the organization scale medical research sites and set them up for success.
Clinical Trials Access Collaborative: Expanding clinical trial participation for all
With the support of McKinsey, the organization launched an expansion of clinical trial capacity at research sites across the United States, enabling more than 20 new trials and reaching over 4,600 participants to date.